Sutro Biopharma (STRO) EBITDA Margin (2017 - 2025)
Sutro Biopharma (STRO) posted EBITDA Margin of -312.74% for Q4 2025, up 115.31 percentage points from -428.05% a year earlier and up 167.59 percentage points from the prior quarter.
Powered by 
Analysis
Sutro Biopharma (STRO) EBITDA Margin (2017 - 2025) Analysis & Trends
For FY2025, Sutro Biopharma's EBITDA Margin came in at -147.38%, up 225.32 percentage points from FY2024.
- Annual EBITDA Margin shows a five-year change of +8.88 percentage points (FY2020 to FY2025).
- In prior years, Sutro Biopharma's EBITDA Margin was -372.70% in FY2024 (-319.06 pp), -53.64% in FY2023 (+128.21 pp), -181.85% in FY2022 (-30.46 pp) and -151.39% in FY2021 (+4.87 pp).
- Quarterly EBITDA Margin has run from a low of -776.06% in Q3 2024 to a high of 39.47% in Q4 2023 over five years.
- On a year-over-year basis, EBITDA Margin has increased in each of the last four quarters, with an average year-over-year change of -27.56 percentage points over the last eight quarters.
- The strongest year-over-year quarter for EBITDA Margin in the past five years was Q4 2023, with a gain of 591.88 percentage points; the weakest was Q3 2024, with a drop of 526.26 percentage points.
- According to Business Quant data, EBITDA Margin for the three prior quarters was -480.34% (Q3 2025), -2.27% (Q2 2025) and -382.86% (Q1 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 35.95% |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 49.01% |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 6.02% |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 33.11% |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 46.01% |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | -124.26% |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 39.16% |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 39.10% |
| 10 | Sutro Biopharma | 265.72 Mn | -412.78 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | -312.74% |
| Sep 30, 2025 | -480.34% |
| Jun 30, 2025 | -2.27% |
| Mar 31, 2025 | -382.86% |
| Dec 31, 2024 | -428.05% |
| Sep 30, 2024 | -776.06% |
| Jun 30, 2024 | -182.43% |
| Mar 31, 2024 | -421.51% |
| Dec 31, 2023 | 39.47% |
| Sep 30, 2023 | -249.79% |
| Jun 30, 2023 | -426.89% |
| Mar 31, 2023 | -320.51% |
| Dec 31, 2022 | -552.41% |
| Sep 30, 2022 | -78.63% |
| Jun 30, 2022 | -64.00% |
| Mar 31, 2022 | -641.09% |
| Dec 31, 2021 | -316.51% |
| Sep 30, 2021 | -393.99% |
| Jun 30, 2021 | -30.96% |
| Mar 31, 2021 | -120.86% |
API Access
Sutro Biopharma EBITDA Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda-margin&ticker=STRO&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda-margin", "ticker": "STRO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebitda-margin&ticker=STRO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();